-
Brand Name: Premarin Vaginal Cream
-
Generic Name: Conjugated Estrogens (USP)
-
Therapeutic Class: Topical Estrogen Therapy
-
Formulation: 0.625 mg conjugated estrogens per gram of cream
-
Delivery System: Graduated applicator for precise dosing
2. COMPOSITION
Component | Concentration | Purpose |
---|---|---|
Conjugated Estrogens (USP) | 0.625 mg/g | Active ingredient |
Cetyl Esters Wax | 7% | Emollient base |
Glycerin | 5% | Humectant |
Propylene Glycol | 3% | Solvent/Preservative |
Methylparaben | 0.18% | Preservative |
3. MECHANISM OF ACTION
-
Local estrogenic effects on vaginal epithelium:
-
Restores vaginal pH (↓ from ~6.0 to ~4.5)
-
Increases blood flow to urogenital tissues
-
Thickens vaginal epithelium (maturation index improvement)
-
Enhances cervical mucus production
-
-
Minimal systemic absorption:
-
Serum estradiol levels typically remain in postmenopausal range
-
First-pass hepatic metabolism avoided
-
4. DOSAGE & ADMINISTRATION
Standard Dosing Schedule
Phase | Dose (g) | Estrogen Content | Frequency | Duration |
---|---|---|---|---|
Initial | 0.5-2 g | 0.31-1.25 mg | Daily | 2-4 weeks |
Maintenance | 0.5-1 g | 0.31-0.625 mg | 2-3× weekly | Ongoing |
Administration Guide
-
Wash hands before application
-
Fill applicator to prescribed dose marking
-
Insert deeply into vagina (best at bedtime)
-
Avoid intercourse for 1 hour post-application
5. INDICATIONS
✅ Moderate-to-severe dyspareunia due to menopause
✅ Vaginal dryness/itching/burning (vulvovaginal atrophy)
✅ Urinary symptoms (dysuria, urgency) from urogenital atrophy
✅ Pre-procedure preparation for postmenopausal pelvic surgery
6. STORAGE CONDITIONS
-
Temperature: 20-25°C (68-77°F)
-
Post-Opening: Use within 3 months
-
Protection: Keep tube tightly closed
-
Do not freeze
7. KEY RECOMMENDATIONS
✔ Start with lowest effective dose (0.5 g daily)
✔ Re-evaluate need every 3-6 months (consider non-hormonal alternatives)
✔ Use vaginal moisturizers concomitantly for optimal symptom relief
✔ Monitor endometrial thickness if used >1 year (transvaginal ultrasound)
8. IMPORTANT SAFETY INFORMATION
Black Box Warnings
⚠ Endometrial Cancer Risk:
-
Unopposed estrogen increases risk (add progestogen if uterus present)
-
Monitor for abnormal bleeding
⚠ Cardiovascular/Thromboembolic Risks:
-
Lower than oral estrogens but still present
Contraindications
❌ Undiagnosed vaginal bleeding
❌ Estrogen-dependent neoplasia
❌ Active arterial thromboembolism
❌ Pregnancy (Category X)
Adverse Effects
Common (≥5%) | Serious (<1%) |
---|---|
Vaginal spotting | Endometrial hyperplasia |
Breast tenderness | Venous thromboembolism |
Headache | Gallbladder disease |
9. COMPARISON WITH OTHER VAGINAL ESTROGENS
Parameter | Premarin Cream | Estradiol Tablet | Vaginal Ring |
---|---|---|---|
Estrogen Type | Conjugated | 17β-estradiol | Estradiol acetate |
Dosing Frequency | 2-3× weekly | Daily | Every 3 months |
Systemic Absorption | Low | Very low | Low |
Cost/Month | $$ | $ | $$$ |
10. PATIENT COUNSELING POINTS
✔ Proper applicator cleaning (wash with mild soap after use)
✔ Expected timeline for improvement (full effects in 1-3 months)
✔ Warning signs to report:
-
New breast lumps
-
Severe headaches
-
Visual changes
-
Leg pain/swelling
✔ Alternate options:
-
Non-hormonal moisturizers (e.g., Replens)
-
Regular sexual activity to maintain blood flow
CONCLUSION
Premarin Vaginal Cream provides effective localized estrogen therapy for urogenital atrophy with minimal systemic effects. While safer than oral estrogens, it still requires regular monitoring and should be used at the lowest effective dose for the shortest duration.
Reviews
There are no reviews yet.